课题基金 / 基金详情

Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E

Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E
PROOFCheck 预防严重急性呼吸衰竭患者 - an E
批准号:
8793043
负责人:
OGNJEN GAJIC
金额:
$61.16万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-19 至 2015-07-31

项目摘要

项目成果

OGNJEN GAJIC的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Severe acute respiratory failure (ARF) requiring prolonged mechanical ventilation is the most common form of acute organ dysfunction in the hospital, and is often associated with multiple organ failure (MOF), high mortality, and functional impairment. Most studies on ARF have focused on patients in the intensive care unit (ICU) after they have been on mechanical ventilation for days and end organ damage is already established. The overall goal of this proposed project is to improve the outcomes of patients at high risk for developing severe ARF and prolonged mechanical ventilation in and outside of the ICU. The project aims to intervene early in high risk patients with an electronic medical records (EMR)-based, patient-centered checklist of common critical care practices aimed at preventing lung injury and hospital acquired adverse events that commonly lead to organ failure (Prevention of Organ Failure checklist - PROOFcheck). This application proposes a stepped-wedge, clustered randomized control trial to determine the utility of PROOFcheck to improve survival and reduce the duration of mechanical ventilation and multiple organ failure in patients identified as high risk for progressing to severe ARF and prolonged mechanical ventilation. The aims in the UH2 phase are: 1) to refine a previously validated Lung Injury Prediction Score into a pragmatic, EMR- based early prediction model to Accurately Predict Prolonged Ventilation (APPROVE), which will automatically identify patients anywhere in the hospital who are at high risk for developing severe ARF requiring mechanical ventilation >48 hours; 2) to incorporate PROOFcheck into the EMR to prompt clinicians on care practices to limit lung injury, prevent adverse events, and avoid additional organ failure; and 3) to establish the infrastructure for the proposed trial. The proposed pragmatic trial will harness the hospital-wide EMR to identify patients at high risk for prolonged mechanical ventilation with APPROVE for intervention with PROOFcheck. As such, the proposed trial aims to break out of the clinical silos by which care is currently organized in the hospital and bring patient-centered, context appropriate care to the acutely ill patient wherever and whenever the patient's condition requires it.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1513/annalsats.201509-626bc
发表时间: 2016
期刊: Annals of the American Thoracic Society
影响因子: 8.3
作者: [Pearl,JoshuaS, Gajic,Ognjen, Dong,Yue, Herasevich,Vitaly, Gong,MichelleN]
通讯作者: Gong,MichelleN
DOI: 10.1186/s13054-018-2194-7
发表时间: 2018-10-30
期刊: Critical care (London, England)
影响因子: --
作者: [Dziadzko MA, Novotny PJ, Sloan J, Gajic O, Herasevich V, Mirhaji P, Wu Y, Gong MN]
通讯作者: Gong MN
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E
Prevention of Severe Acute Respiratory Failure in Patients with PROOFCheck - an E
LIPS-A: Lung Injury Prevention Study with Aspirin
  • 批准号:
    8534467
  • 项目类别:
  • 资助金额:
    $221.76万
  • 财政年份:
    2011
  • 负责人:
    OGNJEN GAJIC
  • 依托单位:
LIPS-A: Lung Injury Prevention Study with Aspirin
  • 批准号:
    8321553
  • 项目类别:
  • 资助金额:
    $238.4万
  • 财政年份:
    2011
  • 负责人:
    OGNJEN GAJIC
  • 依托单位:
海外基金